FDA Announces Recall of Labetalol Hydrochloride Injection: AttorneyOne...

On May 16, the FDA announced that one lot of Labetalol Hydrochloride Injection 100Mg/20 ML (5MG/ML), 20 ML, Multidose Vial by Hospira is recalled due to visible particulates. In light of this news,...(PRWeb May 26, 2014)Read the full story at http://www.prweb.com/releases/2014/05/prweb11883881.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news